Overview and Scope

Cell culture is a process for developing substrates for the safe production of viral vaccines. 3D cell culture is an in vitro technique wherein the cells can grow in an artificially created environment.

Sizing and Forecast

The 3D cell culture technologies market size has grown rapidly in recent years. It will grow from $2.85 billion in 2023 to $3.39 billion in 2024 at a compound annual growth rate (CAGR) of 19.0%. The growth in the historic period can be attributed to advancements in cell biology, drug development, rising incidence of chronic diseases, government funding.

The 3D cell culture technologies market size is expected to see rapid growth in the next few years. It will grow to $6.94 billion in 2028 at a compound annual growth rate (CAGR) of 19.6%. The growth in the forecast period can be attributed to pharmaceutical industry, increasing research and development, environmental and ethical considerations. Major trends in the forecast period include personalized medicine, technological advancements, bioprinting, regenerative medicine.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Segmentation & Regional Insights

The 3d cell culture technologies market covered in this report is segmented –

1) By Type: Scaffold-based, Scaffold-free, 3D Bioreactors

2) By Application: Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine

3) By End Users: Research Laboratories and Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Other End Users

Subsegment: Hydrogels, Polymeric scaffolds, Micropatterned Surface Microplates, Hanging Drop Microplates, Spheroid Microplates, Microfluidic 3D Cell Culture, Magnetic Levitations & 3D Bioprinting

North America was the largest region in the 3D cell culture technologies market in 2023. Western Europe was the second largest region in the 3D cell culture technologies market. The regions covered in the 3d cell culture technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2462&type=smp

Major Driver Impacting Market Growth

The increasing requirement for organ transplantation is driving the 3D Cell Culture Technologies Market. 3D cell culture helps in forming a three-dimensional structure which further helps in mimicking the tissue or organ and therefore helps in organ transplantation. 3D cell structures are capable of tissue and organ regeneration as well as providing the provision for drug toxicology screening. For instance, in January 2023, according to United Network for Organ Sharing (UNOS), a US-based non-profit organization, In 2022, 42,887 organ transplants were performed in the United States, an increase of 3.7% over 2021. A total of 14,903 people became deceased organ donors nationwide in 2022, representing the twelfth consecutive record year for deceased donations and an increase of 7.5% over 2021. As the medical criteria for deceased organ donation continue to broaden based on favorable clinical experience, increasing proportions of donors come from less traditional categories of eligibility. In 2022, 4,776 people donated after circulatory death (DCD donors) as opposed to brain death, representing an increase of nearly 14% over the 2021 total. There were 5,789 deceased donors aged 50 or older, the first time there have been more than 5,000 donors of that age range in a single year.

Key Industry Players

Major companies operating in the 3D cell culture technologies market include Becton Dickinson and Company, Corning Incorporated, Eppendorf AG, GE Healthcare a division of General Electric Company, Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, HiMedia Laboratories Pvt. Ltd., Agilent Technologies Inc., PromoCell GmbH, CellGenix GmbH, Greiner Bio-One International GmbH, Irvine Scientific Sales Company Inc., Cell Culture Company LLC, SeraCare Life Sciences Inc., American Type Culture Collection (ATCC), Miltenyi Biotec B.V. & Co. KG, AITbiotech Pte Ltd, Essen BioScience a Sartorius Company, Sigma-Aldrich, Bel-Art Products Inc., MilliporeSigma, Sumitomo Bakelite, EMD Millipore, Affymetrix Inc., VWR International llc., WHEATON IndustriesInc, Sartorius AG, CN Bio Innovations, Nortis Inc., Kiyatec, Nanofiber Solutions, Copner Biotech, Known Medicine, Synthecon Inc., 3D Biotek LLC, 3D Cell Culture Innovations LLC., 3D Matrix Inc., Allevi Inc., BioSpherix Ltd., Emulate Inc., MicroTissues Inc.

The 3d cell culture technologies market report table of contents includes:



Executive Summary
3D Cell Culture Technologies Market Characteristics
3D Cell Culture Technologies Market Trends And Strategies
3D Cell Culture Technologies Market - Macro Economic Scenario
Global 3D Cell Culture Technologies Market Size and Growth
.

.

.

Global 3D Cell Culture Technologies Market Competitive Benchmarking
Global 3D Cell Culture Technologies Market Competitive Dashboard
Key Mergers And Acquisitions In The 3D Cell Culture Technologies Market
3D Cell Culture Technologies Market Future Outlook and Potential Analysis
Appendix
Top Major Players:

Becton Dickinson and Company
Eppendorf AG
GE Healthcare a division of General Electric Company
Merck KgaA
Thermo Fisher Scientific
Explore the trending research reports from TBRC:



Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]



Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model